Each tablet of Equagesic, for oral administration, contains 200 mg meprobamate and 325 mg aspirin.
As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone. Equagesic is not intended for use longer than 10 days.
Media Articles Related to Equagesic (Meprobamate / Aspirin)
Painkillers for non-cancer chronic pain: New insights on risk
Source: Depression News From Medical News Today [2015.02.21]
Studies show need for alternative, non-medication approachesIt's been seven years since actor Heath Ledger, only 28, was found dead in his Manhattan apartment.
Headaches Quiz: Test Your Headache Pain IQ
Source: MedicineNet Headache Specialty [2015.02.20]
Title: Headaches Quiz: Test Your Headache Pain IQ
Category: MedicineNet Quiz
Created: 9/28/2010 11:09:00 AM
Last Editorial Review: 2/20/2015 5:14:04 PM
New hope in the fight against pain
Source: Neurology / Neuroscience News From Medical News Today [2015.02.19]
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs...
Myofascial Pain Syndrome
Source: MedicineNet Chronic Fatigue Syndrome Specialty [2015.02.19]
Title: Myofascial Pain Syndrome
Category: Diseases and Conditions
Created: 2/4/2005 12:00:00 AM
Last Editorial Review: 2/19/2015 12:00:00 AM
Does Methotrexate Improve Osteoarthritis Pain?
Source: Medscape Pharmacists Headlines [2015.02.18]
Can this disease-modifying antirheumatic drug improve symptoms of osteoarthritis? What does the research find?